Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
Simone Cristina Soares Brandão, Júlia de Oliveira Xavier Ramos, Luca Terracini Dompieri, Emmanuelle Tenório Albuquerque Madruga Godoi, José Luiz de Figueiredo, Emanuel Sarinho, Sarvesh Chelvanambi, Masanori Aikawa
Topics & Concepts
InflammationMedicineImmune systemTLR4ImmunologyTumor necrosis factor alphaToll-like receptorCytokine stormReceptorCytokineDiabetes mellitusRespiratory tractRespiratory systemInternal medicineInnate immune systemCoronavirus disease 2019 (COVID-19)DiseaseEndocrinologyInfectious disease (medical specialty)COVID-19 Clinical Research StudiesRespiratory Support and MechanismsLong-Term Effects of COVID-19